These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26437261)

  • 1. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.
    Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S
    J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
    Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO
    J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy.
    Choi JW; Nam JP; Nam K; Lee YS; Yun CO; Kim SW
    Biomacromolecules; 2015 Jul; 16(7):2132-43. PubMed ID: 26096567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration.
    Kim PH; Kim J; Kim TI; Nam HY; Yockman JW; Kim M; Kim SW; Yun CO
    Biomaterials; 2011 Dec; 32(35):9328-42. PubMed ID: 21924767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.
    Kim J; Nam HY; Kim TI; Kim PH; Ryu J; Yun CO; Kim SW
    Biomaterials; 2011 Aug; 32(22):5158-66. PubMed ID: 21531456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus.
    Moon CY; Choi JW; Kasala D; Jung SJ; Kim SW; Yun CO
    Biomaterials; 2015 Feb; 41():53-68. PubMed ID: 25522965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
    Kwon OJ; Kang E; Choi JW; Kim SW; Yun CO
    J Control Release; 2013 Aug; 169(3):257-65. PubMed ID: 23562633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers.
    Kim J; Kim PH; Nam HY; Lee JS; Yun CO; Kim SW
    J Control Release; 2012 Mar; 158(3):451-60. PubMed ID: 22207073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex.
    Kim J; Li Y; Kim SW; Lee DS; Yun CO
    Biomaterials; 2013 Jun; 34(19):4622-31. PubMed ID: 23541109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model.
    Yoon AR; Kasala D; Li Y; Hong J; Lee W; Jung SJ; Yun CO
    J Control Release; 2016 Jun; 231():2-16. PubMed ID: 26951927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
    Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer.
    Kim J; Nam HY; Choi JW; Yun CO; Kim SW
    Gene Ther; 2014 May; 21(5):476-83. PubMed ID: 24598892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy.
    Kim PH; Kim TI; Yockman JW; Kim SW; Yun CO
    Biomaterials; 2010 Mar; 31(7):1865-74. PubMed ID: 19962189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus armed with VGLL4 selectively kills hepatocellular carcinoma with G2/M phase arrest and apoptosis promotion.
    Xie W; Hao J; Zhang K; Fang X; Liu X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2758-2763. PubMed ID: 30119884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus.
    Kasala D; Lee SH; Hong JW; Choi JW; Nam K; Chung YH; Kim SW; Yun CO
    Biomaterials; 2017 Nov; 145():207-222. PubMed ID: 28869866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
    J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
    Yoo JY; Kim JH; Kwon YG; Kim EC; Kim NK; Choi HJ; Yun CO
    Mol Ther; 2007 Feb; 15(2):295-302. PubMed ID: 17235307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.